Ligand Pharmaceuticals
LGND
LGND
211 hedge funds and large institutions have $1.1B invested in Ligand Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 66 increasing their positions, 74 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
+14
Holders Change %
+7.11%
% of All Funds
3.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
66
Reduced
74
Closed
20
Calls
$4.15M
Puts
$500K
Net Calls
+$3.65M
Net Calls Change
+$2.09M
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$12.3M |
| 2 |
Man Group
London,
United Kingdom
|
-$7.55M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.89M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$4.8M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
-$2.94M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SWA
226
Sutton Wealth Advisors
Tampa,
Florida
| – | -$21.5K | -322 | Closed |
|
227
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
| – | -$11K | -161 | Closed |
|
|
IA
228
IFP Advisors
Tampa,
Florida
| – | -$6K | -30 | Closed |
|
|
USCWA
229
U.S. Capital Wealth Advisors
Austin,
Texas
| – | -$1.87K | -28 | Closed |
|